Diagnamed Holdings Corp. (CSE: DMED)
Canada
· Delayed Price · Currency is CAD
0.0250
0.00 (0.00%)
Jan 31, 2025, 4:00 PM EST
Diagnamed Holdings Company Description
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions.
It focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders; and CERVAI, brain health and wellness AI solution.
It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water.
The company is headquartered in Toronto, Canada.
Diagnamed Holdings Corp.
Country | Canada |
Industry | Health Information Services |
Sector | Healthcare |
CEO | Fabio Chianelli |
Contact Details
Address: 82 Richmond Street East Toronto, British Columbia M5C 1P1 Canada | |
Phone | 416 800 2684 |
Website | diagnamed.com |
Stock Details
Ticker Symbol | DMED |
Exchange | Canadian Securities Exchange |
Fiscal Year | October - September |
Reporting Currency | CAD |
ISIN Number | CA25245D1033 |
SIC Code | 7372 |
Key Executives
Name | Position |
---|---|
Fabio Chianelli | Chairman, President and Chief Executive Officer |
Jing Peng C.A., CPA, CA, CPA, MMPA | Chief Financial Officer |
Andrew Newbury CPA | Corporate Secretary |